TY - JOUR
T1 - Differential expression of MMAC/PTEN in glioblastoma multiforme
T2 - Relationship to localization and prognosis
AU - Sano, Tetsuro
AU - Lin, Huai
AU - Chen, Xiashan
AU - Langford, Lauren A.
AU - Koul, Dimpy
AU - Bondy, Melissa L.
AU - Hess, Kenneth R.
AU - Myers, Jeffrey N.
AU - Hong, Yong Kil
AU - Yung, W. K.Alfred
AU - Steck, Peter A.
PY - 1999/4/15
Y1 - 1999/4/15
N2 - MMAC/PTEN, a tumor suppressor gene located on chromosome 10q, has recently been shown to act as a phosphatidylinositol 3,4,5-triphosphate phosphatase and to modulate cell growth and apoptosis. Somatic mutations of MMAC/PTEN have been reported in a number of human cancers, especially in glioblastoma multiforme (GBM), although the number of identified mutations (~10-35%) is significantly lower than the frequency of LOH affecting the MMAC/PTEN locus in the specimens (~75-95%). To further investigate the possible alterations that may affect MMAC/PTEN, we examined the expression of the gene by reverse transcription-PCR in a series of gliomas. A significant difference (P < 0.001) was observed between the expression of MMAC/PTEN in GBMs versus lower grades of gliomas, thus mimicking the difference in allelic deletion associated with the locus in these tumors. Furthermore, Kaplan- Meier survival plots, adjusted for age and tumor grade, showed a significantly better prognosis for patients whose tumors expressed high levels of MMAC/PTEN. Additionally, immunostaining of GBMs revealed little or no MMAC/PTEN expression in about two-thirds of the tumors, whereas the other approximately one-third of tumors had significantly higher levels of expression. However, in about two-thirds of the high-expressing specimens, a heterogeneous pattern of expression was observed, indicating that certain cells within the tumor failed to express MMAC/PTEN. The combination of these results suggest that, in addition to molecular alterations affecting the gene, altered expression of MMAC/PTEN may play a significant role in the progression of GBM and patient outcome.
AB - MMAC/PTEN, a tumor suppressor gene located on chromosome 10q, has recently been shown to act as a phosphatidylinositol 3,4,5-triphosphate phosphatase and to modulate cell growth and apoptosis. Somatic mutations of MMAC/PTEN have been reported in a number of human cancers, especially in glioblastoma multiforme (GBM), although the number of identified mutations (~10-35%) is significantly lower than the frequency of LOH affecting the MMAC/PTEN locus in the specimens (~75-95%). To further investigate the possible alterations that may affect MMAC/PTEN, we examined the expression of the gene by reverse transcription-PCR in a series of gliomas. A significant difference (P < 0.001) was observed between the expression of MMAC/PTEN in GBMs versus lower grades of gliomas, thus mimicking the difference in allelic deletion associated with the locus in these tumors. Furthermore, Kaplan- Meier survival plots, adjusted for age and tumor grade, showed a significantly better prognosis for patients whose tumors expressed high levels of MMAC/PTEN. Additionally, immunostaining of GBMs revealed little or no MMAC/PTEN expression in about two-thirds of the tumors, whereas the other approximately one-third of tumors had significantly higher levels of expression. However, in about two-thirds of the high-expressing specimens, a heterogeneous pattern of expression was observed, indicating that certain cells within the tumor failed to express MMAC/PTEN. The combination of these results suggest that, in addition to molecular alterations affecting the gene, altered expression of MMAC/PTEN may play a significant role in the progression of GBM and patient outcome.
UR - http://www.scopus.com/inward/record.url?scp=0033561655&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033561655&partnerID=8YFLogxK
M3 - Article
C2 - 10213484
AN - SCOPUS:0033561655
SN - 0008-5472
VL - 59
SP - 1820
EP - 1824
JO - Cancer Research
JF - Cancer Research
IS - 8
ER -